These findings indicate that silencing of FOXO3a and vernodalin treatment in breast cancer cells modulates the expression of cyclinD1, p21Cip and p27Kip1 is FOXO3a/PI3K/Akt dependent manner. The gene discussed is CDKN1B; the disease is breast cancer.